A new approach to the pharmacotherapy of hemophthalmia
Keywords:
hemophthalmus, fibrinolytics,, vitreous body, blood resorption, enzymes,, GemasAbstract
Having studied the comparative effectiveness of various methods of administration of "Gemase" in the
treatment of patients with hemophthalmia, in clinical studies we analyzed the results of treatment of patients who
were divided into 2 groups; in I (n = 25) - in subconjunctival "Gemase"; in II (n = 25) - intravitreal "Gemase". Intravitreal
administration causes accelerated resorption of hemophthalmia and restoration of visual acuity.
References
Иноятов А.Ш. и др. Оценка состояния беременных женщин с диабетом, при заражении COVID-19 //Новый день в медицине. – 2020. – №. 2. – С. 101-103 [Inoyatov A.Sh. et al. Assessment of the condition of pregnant women with diabetes in case of infection with COVID-19 // New day in medicine. – 2020. – no. 2. - S. 101-103.]
Максимов М.Л. и др. Общие вопросы клинической фармакологии и фармакотерапии. – 2020. [Maksimov M.L. et al. General issues of clinical pharmacology and pharmacotherapy. – 2020.]
Мелибоева Ш.Ш. и др. Ботаническая характеристика лекарственного растения «broccoli», фармакологические свойства и химический состав лекарственного растительного сырья «brassica oleracea» //Вестник науки и образования. – 2020. – №. 24-1 (102). – С. 98-102. [Meliboeva Sh.Sh. et al. Botanical characteristics of the medicinal plant "broccoli", pharmacological properties and chemical composition of the medicinal plant raw material "brassica oleracea" // Bulletin of science and education. – 2020. – no. 24-1(102). – S. 98-102.]
Мусаева Д.М. и др. Антибиотики. – 2019. [Musaeva D.M. et al. Antibiotics. – 2019]. 5. Очилов А.К., Мусаева Д.М. Особенности гена CYP2C19 для индивидуализиции фармакотерапии //Новый день в медицине.– 2020. – №. 1. – С. 65-68. [Ochilov A.K., Musaeva D.M. Features of the CYP2C19 gene for individualization of pharmacotherapy //New day in medicine. – 2020. – no. 1. - S. 65-68.]
Очилова Г.С., Мусаева Д.М. Влияние полиморфизма гена MDR-1 на эффективность лечения хронического гастрита // Новый день в медицине. – 2020. – №. 1. – С. 309-312 [Ochilova G.S., Musaeva D.M. Influence of MDR-1 gene polymorphism on the effectiveness of treatment of chronic gastritis // New day in medicine. – 2020. – no. 1. - S. 309-312.]
Салиева М.Х. и др. Анализ профессиональных навыков врачебного персонала многопрофильной клиники по профилактике внутрибольничной инфекции //Новый день в медицине. – 2020. – №. 1. – С. 371-375. [Salieva M.Kh. et al. Analysis of the professional skills of the medical staff of a multidisciplinary clinic for the prevention of nosocomial infection // New day in medicine. – 2020. – no. 1. - S. 371-375.]
Самадов Б.Ш., Мусаева Д.М., Дубинина Н. В. Сравнительная характеристика и тенденции развития эпидемического процесса гепатита С в Украине и в Узбекистане //Новый день в медицине. – 2019. – №. 4. – С. 284-290. [Samadov B.Sh., Musaeva D.M., Dubinina N.V. Comparative characteristics and trends in the development of the epidemic process of hepatitis C in Ukraine and Uzbekistan // New day in medicine. – 2019. – no. 4. - S. 284-290.]
Klichova F.K., Mavlyanov I.R., Musaeva D.M. Influence of genes on pharmacotherapy of ulcer disease //Новый день в медицине. –2020. – №. 2. – С. 147-150.
Oblokulov A.R., Musaeva D.M., Elmuradova A.A. Clinical and epidemiological characteristics of the new coronavirus infection (COVID-19) //New day in medicine. – 2020. – №. 2. – С. 30.
Inoyatov A.Sh. et al. Assessment of the status of pregnant women with diabetes mellitus infected with COVID-19 //New day in medicine. – 2020. – Т. 2. – С. 30.
Tkach V.V. et al. The Theoretical Description for Fluoxetine Electrochemical Determination, Assisted by CoO (OH)-Nanoparticles, Deposited Over the Squaraine Dye //Orbital: The Electronic Journal of Chemistry. – 2021. – Т. 13. – №. 1. – С. 53-57.
Downloads
Published
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.